Simplifying Aquablation reimbursement & documentation

Streamlining Aquablation reimbursement doesn’t have to be complicated. With tools like proudP, collecting IPSS and Qmax data is faster, more reliable, and payer-ready—helping your team reduce paperwork while improving claim approval rates.

Ensuring a smooth reimbursement process for Aquablation therapy still starts with understanding—and meeting—Medicare and private payer documentation requirements. This post walks through the essentials so your team can reduce denials, streamline paperwork, and focus on patient care.

Request Free Clinician Access

Medicare Coverage Criteria

Medicare considers Aquablation reasonable and necessary when performed once in patients who meet all of the following criteria:

• Prostate volume 30–150 cc, confirmed by TRUS

• Persistent moderate-to-severe symptoms despite maximal medical management, including:

  • IPSS ≥12

  • Qmax ≤15 mL/s with a voided volume >125 cc

  • Failure, contraindication, or intolerance to at least 3 months of conventional therapy (e.g., alpha-blockers, PDE5 inhibitors, 5-ARIs)

• The procedure must be performed using an FDA-approved device

Medicare Limitations

Aquablation is not covered for patients with:

• BMI ≥42 kg/m²

• Suspected prostate cancer (unless biopsy confirms negative)

• Significant bladder pathology or active infections

• Inability to safely stop anticoagulation

Private Payer Considerations

Most major U.S. insurers also cover Aquablation, provided that medical necessity is clearly documented. Common requirements include:

• Validated Symptom Scores: Pre- and post-procedure IPSS documentation

• Uroflowmetry (Qmax): Peak flow rate reporting before and after treatment

• Additional criteria: Prostate size limits, post-void residual thresholds, or evidence of prior medical therapy trials

  
  

Key Documentation for Reimbursement Success

1. Prior Authorization

   • Most payers require prior approval

   • Include IPSS, Qmax, TRUS volume, and relevant labs or imaging

2. In-Office Uroflowmetry

   • Standalone reimbursement may be limited

   • But documenting Qmax before and after therapy helps justify necessity and track outcomes

3. Consistent Follow-Up

   • Post-procedure IPSS and Qmax reinforce clinical value

   • Strengthens appeal cases if claims are denied

   
   

Streamlining Documentation with proudP

proudP is a digital uroflowmetry and symptom-tracking platform that simplifies payer compliance:

• Reliable IPSS collection directly from patients

• In-office and at-home Qmax data, integrated into one platform

• Easy export of documentation for prior authorization and claims submission

By aligning your workflow with payer requirements and Medicare guidelines, proudP helps optimize patient access to Aquablation while reducing reimbursement challenges.

Final Thoughts

Aquablation is a powerful option for patients with moderate-to-severe BPH. With proper documentation, most patients can gain coverage. The key is consistency: record IPSS, Qmax, prostate volume, and medication history before submitting for approval.

If your practice has questions about coverage policies—or if you’re looking for ways to streamline uroflowmetry and documentation—proudP is here to support you.

Request free clinician access

We offer doctors and clinicians one month of unlimited access to proudP.

• Review real test results​

• Try it yourself or with staff

• Experience how easy it is to refer and review data

• Build confidence before recommending to patients

Request Free Clinician Access

Book a Coverage Consultation

Learn more about proudP

FAQ

What are the Medicare coverage criteria for Aquablation?

Medicare covers Aquablation once per patient if all criteria are met: prostate volume between 30–150 cc confirmed by TRUS, IPSS ≥12, Qmax ≤15 mL/s with a voided volume >125 cc, and failure/intolerance of at least 3 months of conventional therapy. The procedure must use an FDA-approved device.

Which patients are excluded from Medicare coverage?

Aquablation is not covered for patients with BMI ≥42 kg/m², suspected prostate cancer (unless biopsy is negative), significant bladder pathology or active infections, or those unable to safely stop anticoagulants.

Do private insurers cover Aquablation?

Yes. Most major insurers cover Aquablation when medical necessity is documented. Requirements often include pre- and post-procedure IPSS, uroflowmetry (Qmax), and in some cases, prostate size or post-void residual thresholds.

What documentation is essential for reimbursement success?

Prior authorization is usually required, including IPSS, Qmax, prostate size by TRUS, and lab or imaging results. Consistent follow-up documentation—especially post-procedure IPSS and Qmax—helps justify medical necessity and strengthens appeals.

How can proudP help with Aquablation reimbursement?

proudP provides digital IPSS collection, in-office and at-home Qmax testing, and simple export of documentation for prior authorization and claims. This streamlines payer compliance and reduces administrative burden for providers.